There’s a new year underway. What can we do in 2020 to advance the success of clinical trials for sponsors, CROs, and the patients who ultimately benefit? At ArcheMedX, we firmly believe that a critical path to improving clinical trial readiness is improving your approach to training.
What’s wrong with the
We recently talked with Atlantic Research Group (ARG) executives Shay Brill, VP at ARG, and Erin Farris, Senior Director Project Management, about clinical trial operations, how they are changing, and how they are likely to change. We wanted to share this excerpt from the conversation:
What are your predictions for how clinical operations will work— or should work—in the future?
Over the last year, we’ve been utilizing data analytics more and
We recently talked with Adam Kinsey, Executive Director, Clinical Sciences and Study Management—Oncology at Merck, about staffing clinical trial operations as part of our new interview series Conversations in Clinical Trial Readiness, by ArcheMedX.
We wanted to share this excerpt from the conversation with Adam:
When you are working on the
ArcheMedX is heading west January 12th-15th for the 38th Annual JP Morgan Healthcare Conference. Let's connect in San Francisco to explore how behavioral science and actionable insights can improve clinical trial readiness and commercial success.
Please contact our team to coordinate a specific time to meet during the conference and /
ACHL, Pro-ficiency, Simumetrix and ArcheMedX were recognized for collaboration on The Evolution of Therapies for NSCLC: Navigating New Therapies & Counseling Patients in Clinical Decisions
CHARLOTTESVILLE, Va., May 2, 2018 (Newswire.com) - The Academy of Continued Healthcare Learning (ACHL), Pro-ficiency, Simumetrix and ArcheMedX have been recognized by The National Association of Medical Education Companies (NAMEC) for their innovative collaboration on The Evolution
Charlottesville, VA, May 23, 2017 (Newswire) -The Academy of Continued Healthcare Learning (ACHL), ProPatient, and ArcheMedX have launched a series of integrated online learning programs that have successfully educated and empowered both healthcare providers and patients/caregivers to share decision making in addressing the challenges of treating Idiopathic Pulmonary Fibrosis (IPF)
Although its only October and those of us with children (Max is 7 months old now) are eagerly awaiting a fun filled Halloween, 2016 has already been a remarkable year both personally and for ArcheMedX in terms of customer growth, product evolution, educational impact, and ground breaking research. To elaborate
The Alliance Industry Summit (AIS) Educational Planning Committee of the Alliance for Continuing Education in the Health Professions (ACEhp) recognized the Strategies for Success as a PCMH program as 2016 Best in Class for Educational Outcomes. The award was accepted Monday, May 9th in Philadelphia along with our Partners from
Imedex, the University of Nebraska Medical Center, Center for Continuing Education and College of Nursing Continuing Nursing Education, ArcheMedX, and breast cancer survivors recognized for a unique series of online CME-certified activities
ALPHARETTA, GA (PRWEB) JANUARY 21, 2016
On January 12, 2016, Imedex, LLC, based in in Alpharetta, GA, and its collaborating